Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × niraparib × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 21 Breast Neoplasms 11 Prostatic Neoplasms 10 Fallopian Tube Neoplasms 8 Neoplasms 7 Neoplasm Metastasis 7 Pancreatic Neoplasms 6 Triple Negative Breast Neoplasms 4 Glioblastoma 4 Endometrial Neoplasms 4 Lung Neoplasms 3 Glioma 3 Carcinoma, Ovarian Epithelial 3 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms, Castration-Resistant 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Sarcoma 1 SCLC,Extensive Stage 1 Rectal Neoplasms 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1

Interventions

venetoclax 66 Cyclophosphamide 55 ibrutinib 47 obinutuzumab 45 acalabrutinib 44 Rituximab 42 fludarabine 37 fludarabine phosphate 29 Specimen Handling 27 pirtobrutinib 26 zanubrutinib 24 Biopsy 23 Whole-Body Irradiation 17 Bendamustine Hydrochloride 17 Mycophenolic Acid 14 Magnetic Resonance Spectroscopy 13 Lenalidomide 13 Tacrolimus 9 Peripheral Blood Stem Cell Transplantation 8 idelalisib 7 Sirolimus 7 CT-P10 7 Stem Cell Transplantation 6 Prednisone 6 Busulfan 6 ARQ531 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Melphalan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡